Healeon, a wholly owned subsidiary of Bimini Health Tech, has announced that it received FDA 510(k) clearance for its novel blood separation system for platelet rich plasma (PRP) preparation, the Healeon Duet. Healeon's new Duet technology is exclusively distributed by Suneva Medical, under the trade name Amplifine, in the aesthetic marketplace. "We, at Suneva Medical, are thrilled that Amplifine PRP has obtained 510K clearance and believe that this further strengthens our portfolio and our leadership position as the essential source for facial regenerative aesthetic treatments. We look forward to providing a game-changing technology to our provider partners looking to offer customizable PRP to their patients," said Pat Altavilla, chief executive officer of Suneva Medical.
Read more at PR Newswire >>